National burden of intestinal parasitic infections and its determinants among people living with HIV/AIDS on anti-retroviral therapy in Ethiopia: A systematic review and meta-analysis

被引:4
作者
Akalu, Tadesse Yirga [1 ]
Aynalem, Yared Asmare [2 ]
Shiferaw, Wondimeneh Shibabaw [2 ]
Alamneh, Yoseph Merkeb [3 ]
Getnet, Asmamaw [1 ]
Abebaw, Abtie [1 ]
Atnaf, Aytenew [1 ]
Abate, Abebe [1 ]
Tilahun, Melkamu [3 ]
Kassie, Bekalu [1 ]
Aschale, Yibeltal [1 ]
机构
[1] Debre Markos Univ, Coll Hlth Sci, POB 269, Debre Markos, Ethiopia
[2] Debre Birhan Univ, Coll Hlth Sci, Debre Birhan, Ethiopia
[3] Debre Markos Univ, Sch Med, Debre Markos, Ethiopia
关键词
Intestine; parasite; infections; HIV/AIDS; determinants; meta-analysis; Ethiopia; RISK-FACTORS; OPPORTUNISTIC INFECTIONS; SOUTHERN ETHIOPIA; AIDS PATIENTS; BAHIR DAR; HIV; PREVALENCE; INDIVIDUALS; DIARRHEA;
D O I
10.1177/20503121221082447
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The aim of this systematic review and meta-analysis is designed to assess the pooled prevalence and determine risk factors of intestinal parasitic infections among people living with HIV/AIDS on anti-retroviral therapy in Ethiopia. Methods: International databases: PubMed, Web of Science, Cochrane Library, Scopus, PsycINFO, African Journals Online, and Google Scholar were systematically searched. Publication bias was determined using the funnel plot and Egger's regression tests. Heterogeneity between the studies included in this review was checked by I-2 statistic. The DerSimonian and Laird random-effects model was applied to estimate the pooled effect size. Sub-group, meta-regression, and sensitivity analysis were conducted. Overall, meta-analysis was done using Stata version 14 statistical software. Results: Twenty-seven studies with 8946 individuals were included, the estimated pooled prevalence of intestinal parasitic infections among people living with HIV/AIDS on anti-retroviral therapy was 40.24% (95% confidence interval = 33.8-46.6). Based on sub-group analysis, the highest prevalence was observed in the Tigray region 45.7% (95% confidence interval = 7.983.5), followed by Oromia region 42.2% (95% confidence interval = 28.8-55.6). Availability of latrine (odds ratio = 26.6, 95% confidence interval = 2.8-15.8), presence of animals at home (odds ratio = 2.7, 95% confidence interval = 1.2-5.8), and source of drinking water (odds ratio = 3.2, 95% confidence interval = 1.3-7.5) were significantly associated with intestinal parasitic infections. Conclusion: These findings indicated that the prevalence of intestinal parasites among people living with HIV/AIDS was high in Ethiopia.
引用
收藏
页数:13
相关论文
共 63 条
[11]   Factors Associated with High Prevalence of Intestinal Protozoan Infections among Patients in Sana'a City, Yemen [J].
Alyousefi, Naelah A. ;
Mahdy, Mohammed A. K. ;
Mahmud, Rohela ;
Lim, Yvonne A. L. .
PLOS ONE, 2011, 6 (07)
[12]   Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count [J].
Assefa, Shimelis ;
Erko, Berhanu ;
Medhin, Girmay ;
Assefa, Zelalem ;
Shimelis, Techalew .
BMC INFECTIOUS DISEASES, 2009, 9
[13]   Waterborne transmission of protozoan parasites: Review of worldwide outbreaks - An update 2004-2010 [J].
Baldursson, Selma ;
Karanis, Panagiotis .
WATER RESEARCH, 2011, 45 (20) :6603-6614
[14]   Gastrointestinal and urinary tract pathogenic infections among HIV seropositive patients at the Komfo Anokye Teaching Hospital in Ghana [J].
Yaw Agyekum Boaitey ;
Bernard Nkrumah ;
Ali Idriss ;
Samuel Crowther Kofi Tay .
BMC Research Notes, 5 (1)
[15]   A basic introduction to fixed-effect and random-effects models for meta-analysis [J].
Borenstein, Michael ;
Hedges, Larry V. ;
Higgins, Julian P. T. ;
Rothstein, Hannah R. .
RESEARCH SYNTHESIS METHODS, 2010, 1 (02) :97-111
[16]   Intestinal parasitic infections and determinant factors among school-age children in Ethiopia: a cross-sectional study [J].
Dessie, Awrajaw ;
Gebrehiwot, Tesfay Gebregzabher ;
Kiros, Berihu ;
Wami, Sintayehu Daba ;
Chercos, Daniel Haile .
BMC RESEARCH NOTES, 2019, 12 (01)
[17]  
Dufera M., 2008, ETHIOP J HLTH BIOMED, V1, P11
[18]  
Dwivedi KK, 2007, JPN J INFECT DIS, V60, P76
[19]  
Eshetu T, 2017, ETHIOP J HEALTH SCI, V27, P411, DOI 10.4314/ejhs.v27i4.12
[20]  
Faye B., 2010, J ANTIVIR ANTIRETROV, V2, P11